Fondazione Telethon and Orchard Therapeutics complete transfer of marketing authorization of Strimvelis for ADA-SCID in Europe

01 / 01

Fondazione Telethon will now be responsible for providing the gene therapy to eligible patients in the European Union.

Fondazione Telethon has announced that ERC, the European Research Council, has awarded three researchers from the Telethon Institutes three grants of EUR 1.5 million each for five years.   Specifically, the three researchers are Samuele Ferrari and Attya Omer from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET) in Milan and Ivana Trapani from the Telethon […]

Il tuo browser non è più supportato da Microsoft, esegui l'upgrade a Microsoft Edge per visualizzare il sito.